In the 11 years since being diagnosed with type 2 diabetes, this 54-year-old woman has generally managed to keep her weight, A1C, and lipid profile within acceptable levels. For the past 3 years, though—since menopause— both her weight and her LDL-C levels have been slowly but consistently increasing. The patient indicates that she remains adherent to both her medication and lifestyle regimens, including daily walks. How would you manage the care of this patient?
Primary care physicians, physician assistants, and nurse practitioners.
After taking part in this educational activity, participants should be better able to:
- Identify patients who are at risk for cardiovascular (CV) complications due to comorbid diabetes and dyslipidemia
- Explain the pathophysiologic interrelationship among CV disease, diabetes, and dyslipidemia
- Implement patient-specific therapeutic strategies to achieve optimal glycemic and lipid levels
- Educate patients about CV risk reduction through adherence to a combined regimen of medication use and therapeutic lifestyle changes
AMA PRA Category 1 Credit(s)TM
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Albert Einstein designates this enduring educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Michael Davidson, MD
Clinical Professor of Medicine
Director, Preventive Cardiology
University of Chicago Medical Center
Jorge Plutzky, MD
Director, The Vascular Disease Prevention Program
Brigham and Women's Hospital
Associate Professor, Cardiovascular Medicine
Harvard Medical School
CME Course Director
Daniel Thomas Stein, MD
Professor, Department of Medicine (Endocrinology)
Albert Einstein College of Medicine of Yeshiva University
Conflict of Interest
The Conflict of Interest Disclosure Policy of Albert Einstein College of Medicine of Yeshiva University requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.
Michael Davidson, MD, is on the board of directors of Omthera Pharmaceuticals and is a consultant for Amgen Inc, AstraZeneca, Merck & Co., Inc., and sanofi-aventis.
Jorge Plutzky, MD, is a consultant for Abbott, Amylin Pharmaceuticals, Bristol-Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Merck & Co. Inc., Novo Nordisk, Orexigen, Pfizer, Roche/Genentech, Takeda, and Vivus.
Daniel Thomas Stein, MD, has nothing to disclose.
Jill Rovitzky Black and Melissa Johnson, Haymarket Medical Education, have nothing to disclose with regard to commercial support.
The staff of the Center for Continuing Medical Education of Albert Einstein College of Medicine has nothing to disclose relative to this CME activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. Albert Einstein College of Medicine, Daiichi Sankyo, Inc., and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine, Daiichi Sankyo, Inc., and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Sponsored by Albert Einstein College of Medicine of Yeshiva University
Produced by Haymarket Medical Education
This program supported by an educational grant from Daiichi Sankyo, Inc.
To obtain credit, a score of 70% or better is required. This CME is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.
If you have any questions relating to the accreditation of this activity, please contact Mildred Adighiuzor, Associate Director, CME Business & Marketing, at 718-920-6674.
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.